Pharmacokinetics of the four combination regimens of dihydroartemisinin/ mefloquine in acute uncomplicated falciparum malaria

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 36, Issue 1, 2005, Pages 23-33

  Na Bangchang, Kesara ^a,c   Thanavibul, A ^a   Tippawangkosol, P ^b   Karbwang, J ^a,d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

^c THAMMASAT UNIVERSITY   (Thailand)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; DIHYDROARTEMISININ; MEFLOQUINE;

ACUTE UNCOMPLICATED FALCIPARUM MALARIA; ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DOSE REGIMEN; DRUG SCREENING; DRUG TOLERABILITY; FOLLOW UP; HUMAN; MALARIA FALCIPARUM; PARAMETER; PARASITEMIA; PATIENT COMPLIANCE; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE;

EID: 17744362338     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Batty KT, Ilett KF, Edwards G, et al. Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes. Br J Pharmacol 1998; 125: 159-67.
2. Bernakis A, Paris M, Loutan L, Plessas CT, Plessas ST. Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers. Am J Trop Med Hyg 1997; 56: 17-23.
3. Boudreau EF, Fleckenstein L, Pang LW, et al. Mefloquine kinetics in cured and recrudecent patients with acute falciparum malaria and in healthy volunteers. Clin Pharmacol Ther 1990; 48: 399-409.
4. Bunnag D, Kanda T, Karbwang J, Pungpak S, Harinasuta T. Artemether or artesunate followed by mefloquine as a possible treatment for multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1996; 90: 415-7.
5. th ed. London: Lee and Febiger, 1991: 14-23.
6. 3H]- dihydroartemisinin by erythrocytes infected with Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 1984; 78: 265-70.
7. Harinasuta T, Karbwang J. Qinghaosu: a promising antimalarial. JAMA SEA 1994; 34: 7-8.
8. Hein TT. An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Vietnam. Trans R Soc Trop Med Hyg 1994; 88 (suppl): 7-8.
9. Karbwang J, Na-Bangchang K, Molunto P, Banmairuroi V, Congpuong K. Determination of artemether and its major metabolite, dihydroartemisinin in plasma using high performance liquid chromatography with electrochemical detection. J Chromatogr B 1987; 690: 259-65.
10. Karbwang J, Back DJ, Bunnag D, Breckenridge AM. A comparison of the pharmacokinetics of mefloquine in healthy Thai volunteers and in Thai patients with falciparum malaria. Eur J Clin Pharmacol 1988; 35: 677-80.
11. Karbwang J, Molunto P, Na-Bangchang K, Bunnag D. Determination of mefloquine in biological fluids by high performance liquid chromatography. Southeast Asian J Trop Med Public Health 1989a; 20: 55-60.
12. Karbwang J, Na-Bangchang K, Molunto P, Bunnag D. Determination of quinine and quinidine in biological fluids by high performance liquid chromatography. Southeast Asian J Trop Med Public Health 1989b; 20: 65-9.
13. Karbwang J, Na-Bangchang K, Back DJ, Bunnag D. Effect of ampicillin on mefloquine pharmacokinetics in Thai males. Eur J Clin Pharmacol 1991; 40: 631-3.
14. Karbwang J, Na-Bangchang K, Congpuong K, Molunto P, Thanavibul A. Pharmacokinetics and bioavailability of oral and intramuscular artemether. Eur J Clin Pharmacol 1997; 52: 307-10.
15. Karbwang J, Na-Bangchang K, Congpoung K, Thanavibul A, Harinasuta T. Pharmacokinetics of oral artesunate in Thai patients with uncomplicated falciparum malaria. Clin Drug Invest 1998a; 15: 37-73.
16. Karbwang J, Na-Bangchang K, Congpoung K, Thanavibul A, Wattanakoon Y, Molunto P. Pharmacokinetics of oral artemether in Thai patients with uncomplicated falciparum malaria. Fund Clin Pharmacol 1998b; 12: 242-4.
17. Karbwang J, Na-Bangchang K, Thanavibul A, Back DJ, Bunnag D, Harinasuta T. Pharmacokinetics of mefloquine alone or in combination with artesunate. Bull WHO 1994; 72: 83-7.
18. Lee IS, Hufford CD. Metabolism of antimalarial sesquiterpene lactones. Pharmacol Ther 1990; 48: 345-55.
19. Li GQ, Guo XB, Fu LC, Jian HX, Wang XH. Clinical trails of artemisinin and its derivatives in the treatment of malaria in China. Trans R Soc Trop Med Hyg 1994; 88 (suppl): 5.
20. Luo XD, Shen CC. The chemistry, pharmacology and clinical applications of qinghaosu (artemisinin) and its derivatives. Med Res Rew 1987; 7: 29-52.
21. Maggs JL, Madden S, Bishop LP, O'neill PM, Park BK. The rat biliary metabolites of dihydroartemisinin, an antimalarial endoperoxide. Drug Met Dispos 1997; 25: 1200-4.
22. Myint PT, Shwe T, Lin S. Clinical study of the treatment of cerebral malaria with artemether (qinghaosu derivative). Trans R Soc Trop Med Hyg 1989; 83: 72.
23. Na-Bangchang K, Congpoung K, Hung LN, Molunto P, Karbwang J. A simple high performance liquid chromatography with electrochemical detection for simultaneous determination of artesunate and dihydroartemisinin in biological fluids. J Chromatgr B 1988; 708: 201-7.
24. Na-Bangchang K, Congpoung K, Sirichaisinthop J, Suprakorb K, Karbwang J. Compliance with a 2-day combination of mefloquine/artemether in multidrug resistant Plasmodium falciparum malaria. Br J Clin Pharmacol 1997; 43: 639-42.
25. Na-Bangchang K, Karbwang J, Congpoung K, Thanavibul A, Ubalee R. Pharmacokinetic and bioequivalence evaluation of the two generic formulations of oral artesunate. Eur J Clin Pharmacol 1998; 53: 375-6.
26. Na-Bangchang K, Karbwang J, Molunto P, Banmairuroi V, Thanavibul A. Pharmacokinetics of mefloquine when given alone and in combination with artemether, in patients with uncomplicated falciparum malaria. Fund Clin Pharmacol 1995a; 9: 576-82.
27. Na-Bangchang K, Molunto P, Banmairuroi V, Thanavibul A, Karbwang J. Pharmacokinetics of mefloquine when given as a single and two divided-dose regimens. Int J Clin Pharm Res 1995b; XV: 215-20.
28. Na-Bangchang K, Tippawangkosol P, Thanavibul A, Ubalee R, Karbwang J. Pharmacokinetic and pharmacodynamic interactions of mefloquine and dihydroartemisinin. Int J Clin Pharm Res 1999a; XIX: 19-27.
29. Na-Bangchang K, Tippawangkosol P, Ubalee R, Chaovanakawee S, Saenglertsilapachai S, Karbwang J. Comparative clinical trial of four regimens of dihydroartemisinin-mefloquine in multidrug-resistant falciparum malaria. Trop Med Int Health 1999b; 4: 602-10.
30. Svensson USH, Ashton M, Hai TN, et al. Artemisinin induced omeprazole metabolism in human beings. Clin Pharmacol Ther 1998; 64: 160-7.
31. Teja-isavadharm, Nosten F, Kyle DE, et al. Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay. Br J Clin Pharmacol 1996; 599-604.
32. Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta Trop 1994; 56: 143-6.